SCHEMBL21447925

SCHEMBL21447925

O=C(OCc1ccccc1)[C@H](O)CCc1ccc(C(F)(F)F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.46
PLAAT3 P53816 1/20 0.46
PLAAT5 Q96KN8 1/20 0.46
PLAAT2 Q9NWW9 1/20 0.46
PLAAT4 Q9UL19 1/20 0.46
PPARG P37231 6/20 0.46
PPARA Q07869 6/20 0.46
MMP12 P39900 2/20 0.45
MMP1 P03956 1/20 0.45
FFAR1 O14842 1/20 0.45
FFAR4 Q5NUL3 1/20 0.45
PTPRC P08575 1/20 0.44
PTPN1 P18031 1/20 0.44
PDPK1 O15530 1/20 0.44
TACR1 P25103 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GPR55 Q9Y2T6 1/20 0.43
LTA4H P09960 1/20 0.43
EPHX2 P34913 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5014403 0.87 ALDH1A1 (0.52) MMP12KMT2ALTA4H
SCHEMBL5014406 0.87 ALDH1A1 (0.52) MMP12KMT2ALTA4H
SCHEMBL7373327 0.87 ALDH1A1 (0.52) MMP12KMT2ALTA4H
SCHEMBL19244967 0.86 POLB (0.47) MMP12MEN1KMT2A
SCHEMBL18256291 0.86 PPARG (0.53) MGLLPPARGPPARAMMP12MMP1
SCHEMBL28321341 0.86 PPARG (0.53) MGLLPPARGPPARAMMP12MMP1
SCHEMBL21447860 0.85 PPARG (0.50) MGLLPLAAT3PLAAT5PLAAT2PLAAT4
SCHEMBL21159845 0.84 SCN9A (0.52) MMP12FFAR1FFAR4KMT2ALTA4H
SCHEMBL21447926 0.84 ALDH1A1 (0.45) MGLLPLAAT3PLAAT5PLAAT2PLAAT4
SCHEMBL27410029 0.82 KMT2A (0.47) MMP12MMP1FFAR1FFAR4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11382949-B2 Anthelmintic depsipeptide compounds Boehringer Ingelheim Animal Health USA Inc. (US) 2022-07-12 US disclosed
US-10793604-B2 Anthelmintic depsipeptide compounds Boehringer Ingelheim Animal Health USA Inc. (US) 2020-10-06 US disclosed
US-20190307838-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS Boehringer Ingelheim Animal Health USA Inc. (US) 2019-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11382949-B2 Anthelmintic depsipeptide compounds ENPP2, ROCK2, RRP12 MGLL 4290/4885PLAAT3 2358/4885PLAAT5 2547/4885
US-10793604-B2 Anthelmintic depsipeptide compounds VIP, PREP, DNPEP MGLL 1064/4885PLAAT3 1650/4885PLAAT5 914/4885
US-20190307838-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS ENPP2, ROCK2, RRP12 MGLL 4290/4885PLAAT3 2358/4885PLAAT5 2547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.